What's the point of ST elevation?

Emergency Medicine Journal

Volumn 19, Issue 2, 2002, Pages 126-128

  Carley, S D ^a   Gamon, R ^b   Driscoll, P A ^b   Brown, G ^c   Wallman, P ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPETENCE; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; EMERGENCY WARD; FIBRINOLYTIC THERAPY; GENERAL PRACTITIONER; HUMAN; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL STAFF; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; SAMPLE SIZE; ST SEGMENT ELEVATION; TEACHING HOSPITAL; UNITED KINGDOM;

EID: 0036208743     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.19.2.126     Document Type: Article

References (24)

1. Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: New evidence from Grampian region early antistreplase trial (GREAT)
2. Indications of fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results of all trials of more than 1000 patients
3. Observer variation in measured ST segment
4. Physician electrocardiogram reading in the emergency department - Accuracy and effect on triage decisions: Findings from a multicentre study
5. Interpretation of the electrocardiogram in suspected myocardial infarction: A randomised controlled study of the effect of a training program to reduce interobserver variation
6. Prevention of myocardial damage in acute myocardial ischaemia by early treatment with intravenous streptokinase
7. Randomised trial of intravenous recombinant tissue type plasminogen activate versus intravenous streptokinase in acute myocardial infarction: Report from the European cooperative Study Group for Recombinant Tissue-type Plasminogen Activator
8. Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled clinical trial
9. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
10. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): Mortality, morbidity, and infarct size at 21 days
11. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
12. Thrombolysis and angioplasty in myocardial infarction (TAMI-1) trial: Influence of infarct location on arterial patency, left ventricular function and mortality
13. Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge
14. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
15. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET)